名字
发表于 2025-3-30 08:54:22
Conclusion: Revising British Millenarianismhesia, and, rarely, ulceration of the fingers and toes (and in some cases of the ears or nose). Primary or idiopathic Raynaud phenomenon (Raynaud disease) occurs without an underlying disease. Secondary Raynaud phenomenon (Raynaud syndrome) occurs in association with an underlying disease – usually
conceal
发表于 2025-3-30 12:47:14
http://reply.papertrans.cn/28/2707/270647/270647_52.png
一再困扰
发表于 2025-3-30 18:22:28
The Aesthetics of Process and Human Lifeverse disorders based on epidemiology, pathology, or diagnostic criteria, in fact the underlying immunogenetic mechanism might be similar. The clinical evidence supporting the common origin of autoimmune diseases corresponds to the kaleidoscope of autoimmunity, which is the co-occurrence of various
Digitalis
发表于 2025-3-30 20:44:30
http://reply.papertrans.cn/28/2707/270647/270647_54.png
coltish
发表于 2025-3-31 03:38:39
https://doi.org/10.1007/978-94-011-0247-6h giant cell arteritis. The typical symptoms are bilateral aching of the shoulder girdle, associated with morning stiffness. The neck and hip girdle may also be involved. The diagnosis of polymyalgia rheumatica is made primarily on clinical grounds. There is no single diagnostic test, but sets of di
小淡水鱼
发表于 2025-3-31 06:28:00
http://reply.papertrans.cn/28/2707/270647/270647_56.png
malapropism
发表于 2025-3-31 10:19:16
Auswahl potenzieller Maschinenlieferanten,nown. Several viral infections, such as hepatitis B virus infection, may be associated with blood vessel inflammation, clinically and histologically indistinguishable from PAN. Clinical manifestations of PAN are heterogeneous and multisystemic. Peripheral nerve and skin are frequently involved. Othe
Blemish
发表于 2025-3-31 14:34:05
http://reply.papertrans.cn/28/2707/270647/270647_58.png
Intractable
发表于 2025-3-31 21:10:42
http://reply.papertrans.cn/28/2707/270647/270647_59.png
neurologist
发表于 2025-3-31 22:55:25
Antiphospholipid Syndromently accompanied by a moderate thrombocytopenia, in the presence of antiphospholipid antibodies (aPL). Some estimates indicate that the incidence of the APS is around 5 new cases per 100,000 persons per year and the prevalence around 40–50 cases per 100,000 persons. The prevalence is higher among pa